0000950170-24-039316.txt : 20240401
0000950170-24-039316.hdr.sgml : 20240401
20240401160842
ACCESSION NUMBER: 0000950170-24-039316
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240328
FILED AS OF DATE: 20240401
DATE AS OF CHANGE: 20240401
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McLoughlin Sean
CENTRAL INDEX KEY: 0002007879
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41365
FILM NUMBER: 24809249
MAIL ADDRESS:
STREET 1: C/O HILLEVAX, INC.
STREET 2: 321 HARRISON AVE, SUITE 500
CITY: BOSTON
STATE: MA
ZIP: 021118
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HilleVax, Inc.
CENTRAL INDEX KEY: 0001888012
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 321 HARRISON AVE, SUITE 500
CITY: BOSTON
STATE: MA
ZIP: 02118
BUSINESS PHONE: (617) 213-5054
MAIL ADDRESS:
STREET 1: 321 HARRISON AVE, SUITE 500
CITY: BOSTON
STATE: MA
ZIP: 02118
4
1
ownership.xml
4
X0508
4
2024-03-28
0001888012
HilleVax, Inc.
HLVX
0002007879
McLoughlin Sean
C/O HILLEVAX, INC.
321 HARRISON AVE, SUITE 500
BOSTON
MA
02118
false
true
false
false
Chief Operating Officer
false
Common Stock
2024-03-28
4
P
false
1250
16.98
A
1250
D
/s/ Paul Bavier, Attorney-in-Fact for Sean McLoughlin
2024-04-01